Elekta announces new president and CEO

Elekta, a radiation therapy technology company based out of Stockholm, Sweden, announced this week that its board of directors has appointed Richard Hausmann its new president and CEO. Hausmann will join the company on May 1 and take over as president and CEO in June.

Laurent Leksell, Elekta founder and chairman of the board of directors, praised Hausmann’s years of experience with companies such as General Electric and Siemens.

“Richard Hausmann joins us with nearly three decades of experience in the medical device industry,” Leksell said in a prepared statement. “He led GE’s Magnetic Resonance (MR) division as President and CEO, served as President and CEO of Siemens computed tomography (CT) and worked at Siemens in leading positions in its MR business. He also acted as CEO of Siemens China, responsible for the company’s entire portfolio in its core emerging market. Richard has a solid track record of bringing clinical innovations to the global health care market and is known for his deep insights into customer and patient needs, with a strong outcome orientation.”

“I very much look forward to joining Elekta and the opportunity to contribute to its remarkable track record as the leading innovator in radiation oncology and neurosurgery,” Hausmann said in the same statement. “I am excited about Elekta, a customer and patient focused company, and its offering of advanced clinical solutions.”

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.